Pancreatogastrostomy versus Pancreatojejunostomy: An Up-to-Date Meta-Analysis of RCTs

Int J Surg Oncol. 2017:2017:7526494. doi: 10.1155/2017/7526494. Epub 2017 Jul 17.

Abstract

Background: A meta-analysis was conducted in order to provide an up-to-date comparison of pancreatogastrostomy (PG) and pancreatojejunostomy (PJ), after pancreatoduodenectomy (PD), in terms of clinically significant postoperative pancreatic fistula (POPF) and other postoperative complications.

Methods: This meta-analysis was conducted according to the PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. A systematic literature search in MEDLINE and Cochrane Central Register of Controlled Clinical Trials was performed. Fixed Effects or Random Effects model was used, based on the Cochran Q test.

Results: In total, 10 studies (1629 patients) were included. There was no statistical significance between PG and PJ regarding the rate of clinically significant POPF (OR: 0.70, 95%CI: 0.46-1.06). PG was associated with a higher rate of postpancreatoduodenectomy haemorrhage (PPH) (OR: 1.52, 95%CI: 1.08-2.14). There was no difference between the two techniques in terms of clinically significant PPH (OR: 1.35, 95%CI: 0.95-1.93) and clinically significant postoperative delayed gastric emptying (DGE) (OR: 0.98, 95%CI: 0.59-1.63).

Discussion: There is no difference between the two anastomotic techniques regarding the rate of clinically significant POPF. Given several limitations, more large scale high quality RCTs are required.

Publication types

  • Comparative Study
  • Meta-Analysis
  • Review

MeSH terms

  • Ampulla of Vater / surgery
  • Anastomosis, Surgical / adverse effects
  • Digestive System Neoplasms / surgery
  • Gastrostomy* / adverse effects
  • Humans
  • Pancreas / surgery*
  • Pancreatic Fistula / etiology
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy* / adverse effects
  • Pancreaticojejunostomy* / adverse effects
  • Randomized Controlled Trials as Topic
  • Stomach / surgery*